These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16027268)

  • 41. Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
    May HT; Muhlestein JB; Carlquist JF; Horne BD; Bair TL; Campbell BA; Kfoury AG; Lyon JL; Kim H; Renlund DG
    Am J Cardiol; 2006 Sep; 98(5):653-8. PubMed ID: 16923455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
    Chong AY; Lip GY
    Eur J Heart Fail; 2007 Feb; 9(2):124-8. PubMed ID: 16859990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary prevention of atrial fibrillation by statins: still unresolved?
    Crijns HJ
    Eur Heart J; 2009 Oct; 30(19):2302-3. PubMed ID: 19717849
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary and secondary prevention of heart failure with statins.
    Udell JA; Ray JG
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):917-26. PubMed ID: 17173505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of chronic heart failure with statins: potential advantages and disadvantages].
    Li WM; Kong YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):774-5. PubMed ID: 17217680
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of statins beyond lipid lowering: potential for clinical benefits.
    Almuti K; Rimawi R; Spevack D; Ostfeld RJ
    Int J Cardiol; 2006 Apr; 109(1):7-15. PubMed ID: 16054715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized clinical outcome trials of statins in heart failure.
    Fonarow GC
    Heart Fail Clin; 2008 Apr; 4(2):225-9. PubMed ID: 18433703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
    Lavie CJ; Mehra MR
    Congest Heart Fail; 2009; 15(4):157-8. PubMed ID: 19627287
    [No Abstract]   [Full Text] [Related]  

  • 50. CORONA study highlights challenges of treating older patients with systolic heart failure.
    Cardiovasc J Afr; 2007; 18(6):402-4. PubMed ID: 18092121
    [No Abstract]   [Full Text] [Related]  

  • 51. Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients.
    Anker SD; Clark AL; Winkler R; Zugck C; Cicoira M; Ponikowski P; Davos CH; Banasiak W; Zardini P; Haass M; Senges J; Coats AJ; Poole-Wilson PA; Pitt B
    Int J Cardiol; 2006 Sep; 112(2):234-42. PubMed ID: 16846656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins in heart failure. Beyond the lipid lowering effect.
    Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostics and therapy of diastolic heart failure].
    Schmidt A; Pieske B
    MMW Fortschr Med; 2009 Apr; 151(15):27-30. PubMed ID: 19728677
    [No Abstract]   [Full Text] [Related]  

  • 54. Chronic heart failure: an overview of conventional treatment versus novel approaches.
    Landmesser U; Drexler H
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):628-38. PubMed ID: 16306919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statins in heart failure - a failure?
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):397-401. PubMed ID: 18579352
    [No Abstract]   [Full Text] [Related]  

  • 56. N-3 polyunsaturated fatty acids and statins in heart failure.
    Florkowski C; Molyneux S; George P; Lever M; Richards M
    Lancet; 2009 Jan; 373(9661):379-80; author reply 380-1. PubMed ID: 19186267
    [No Abstract]   [Full Text] [Related]  

  • 57. Statin therapy in congestive heart failure.
    Keller KB; Lemberg L
    Am J Crit Care; 2005 Jul; 14(4):338-40. PubMed ID: 15980426
    [No Abstract]   [Full Text] [Related]  

  • 58. Statins in the treatment of chronic heart failure: biological and clinical considerations.
    van der Harst P; Voors AA; van Gilst WH; Böhm M; van Veldhuisen DJ
    Cardiovasc Res; 2006 Aug; 71(3):443-54. PubMed ID: 16730683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The GISSI-HF trial].
    Tavazzi L; Nodari S
    G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
    [No Abstract]   [Full Text] [Related]  

  • 60. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.